Evidence map›Paper›PMID 26691022›Full record

ArticlePloS one2015

Cyclophilin C Participates in the US2-Mediated Degradation of Major Histocompatibility Complex Class I Molecules.

Daniel C Chapman, Pawel Stocki, David B Williams

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma.International journal of molecular sciences · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniel C ChapmanDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Pawel StockiDepartment of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
David B WilliamsDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
University of Toronto · CA

Funding

Canadian Institutes of Health Research MOP-123226
6 · The paper itself

Abstract

Human cytomegalovirus uses a variety of mechanisms to evade immune recognition through major histocompatibility complex class I molecules. One mechanism mediated by the immunoevasin protein US2 causes rapid disposal of newly synthesized class I molecules by the endoplasmic reticulum-associated degradation pathway. Although several components of this degradation pathway have been identified, there are still questions concerning how US2 targets class I molecules for degradation. In this study we identify cyclophilin C, a peptidyl prolyl isomerase of the endoplasmic reticulum, as a component of US2-mediated immune evasion. Cyclophilin C could be co-isolated with US2 and with the class I molecule HLA-A2. Furthermore, it was required at a particular expression level since depletion or overexpression of cyclophilin C impaired the degradation of class I molecules. To better characterize the involvement of cyclophilin C in class I degradation, we used LC-MS/MS to detect US2-interacting proteins that were influenced by cyclophilin C expression levels. We identified malectin, PDIA6, and TMEM33 as proteins that increased in association with US2 upon cyclophilin C knockdown. In subsequent validation all were shown to play a functional role in US2 degradation of class I molecules. This was specific to US2 rather than general ER-associated degradation since depletion of these proteins did not impede the degradation of a misfolded substrate, the null Hong Kong variant of α1-antitrypsin.

Indexed as

Host-Pathogen InteractionsCell LineCyclophilin CCyclophilinsCytomegalovirusEndoplasmic Reticulum-Associated DegradationHistocompatibility Antigens Class IHLA-A2 AntigenHumansLectinsMembrane ProteinsProtein Disulfide-IsomerasesRNA-Binding ProteinsTandem Mass SpectrometryViral Envelope ProteinsViral Proteinscyclophilin BCyclophilin CCyclophilinsHistocompatibility Antigens Class IHLA-A2 AntigenLectinsMembrane ProteinsMLEC protein, humanPDIA6 protein, humanProtein Disulfide-IsomerasesRNA-Binding Proteinstransmembrane protein 33, humanUS11 protein, herpesvirusUS2 protein, VaricellovirusViral Envelope ProteinsViral Proteins

Identifiers

PMID26691022
PMCPMC4686535
OpenAlexW2205475424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.